Navigation Links
Researchers pursuing arthritis protein
Date:1/9/2014

Chronic inflammation poses something of a mystery for researchers. If we become infected, the body immediately takes steps to repair and tidy it up. This process manifests itself as inflammation, which stems from a high level of activity in the immune cells, the body's defence against bacteria and viruses. But it does not always go according to plan. Every so often, the body's immune system over-reacts, and the inflammation develops into a chronic condition, resulting in diseases such as arthritis, inflammatory bowel disease and psoriasis. However, researchers are now a step closer to understanding what happens when the immune system over-reacts and causes chronic inflammation.

"Through analysing blood cells, we have observed that a particular protein called TL1A can get healthy cells to behave like those we see in chronic inflammation. This is bringing us closer to unlocking the mystery of inflammation," says Kirsten Reichwald, PhD student at the Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen. The results have been published in PLOS ONE.

Biological treatment fights arthritis

Today, doctors can use so-called biological medicines for treating arthritis, which has radically changed the outlook for patients. Biological treatment works by impeding the harmful substances that are partly responsible for advancing the chronic inflammation in the body. Almost 40 per cent of arthritis patients experience a positive effect when taking biological medicines.

"Existing biological treatment means that doctors today can halt the diseases instead of just relieving the symptoms," explains Kirsten Reichwald.

However, in order to block the right substances, doctors need detailed information about the processes that cause chronic inflammation. The researchers therefore studied cells from 50 blood donors from the blood bank at Rigshospitalet in Copenhagen, and concluded that the protein TL1A has a key role in the development of the inflammation.

"Our latest findings tell us, that the TL1A protein takes part in driving the inflammation, and therefore it makes sense to try and block the protein with biological medicines," says Kirsten Reichwald, who hopes that her future research will help to provide even more specific knowledge about inflammation.

What the researchers did

The researchers studied blood cells from blood donors in a proinflammatory environment with and without the TL1A protein. Analysed how the cells had developed, how they grew, and whether they resembled those that the researchers see in chronic inflammation. The healthy blood cells stem from the blood bank at Rigshospitalet in Copenhagen, and more than 50 donors have been examined with the same result.


'/>"/>

Contact: Kirsten Reichwald
kire@sund.ku.dk
45-61-68-65-76
University of Copenhagen
Source:Eurekalert

Related biology news :

1. Researchers discover a tumor suppressor gene in a very aggressive lung cancer
2. Researchers unveil rich world of fish biofluorescence
3. Researchers propose alternative way to allocate science funding
4. New organization brings together top researchers to sequence the genomes of invertebrates
5. Plan to delist gray wolf endangers other threatened species, researchers find
6. Researchers say fructose does not impact emerging indicator for cardiovascular disease
7. Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis
8. Researchers create largest evolutionary timetree of land plants to investigate traits that permit survival in cold climates
9. Penn researchers grow liquid crystal flowers that can be used as lenses
10. UT Southwestern neuroscience researchers identify gene involved in response to cocaine
11. ASU researchers develop new device to help image key proteins at room temperature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Drug Discovery Services portfolio to include an array of biochemical analyses critical ... reliable data to drive their hit-to-lead and SAR programs, including inhibitor potency and ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift ... new partnership with Compass Research . GGI's mission is to advance global health ... a child in need in honor of each clinical trial volunteer. The vision of ...
(Date:2/22/2017)... 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics ... biopharmaceutical products for companion animals, will host a live conference ... to discuss financial results from the fourth quarter and full ... and investors may access the audio webcast or ... ...
Breaking Biology Technology: